Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study

We investigated the impact of season relative to other determinants of chronic obstructive pulmonary disease (COPD) exacerbation frequency in a long-term international study of patients with forced expiratory volume in 1 s (FEV1) <60% predicted. COPD exacerbations were defined by worsening symptoms requiring systemic corticosteroids and/or antibiotics (moderate) or hospital admission (severe). Seasonality effect was calculated as the proportion of patients experiencing an exacerbation each month. Exacerbations in the northern and southern regions showed an almost two-fold increase in the winter months. No seasonal pattern occurred in the tropics. Overall, 38% of exacerbations were treated with antibiotics only, 19% with systemic corticosteroids only and 43% with both, while 20% required hospital admission irrespective of the season. Exacerbation frequency was associated with older age, lower body mass index, lower FEV1 % pred and history of prior exacerbations. Females and patients with worse baseline breathlessness, assessed using the Medical Research Council (MRC) dyspnoea scale, exacerbated more often (rate ratio (RR) for male versus female 0.7, 95% CI 0.7–0.8 (p<0.001); RR for MRC dyspnoea score 3 versus 1 and 2 combined 1.1, 95% CI 1.1–1.2 (p<0.001)). The effect of season was independent of these risk factors. COPD exacerbations and hospitalisations were more frequent in winter.

[1]  F. Martínez,et al.  La enfermedad pulmonar obstructiva crónica y las estaciones del año , 2000 .

[2]  F. Chew,et al.  Seasonal trends of viral respiratory tract infections in the tropics , 1998, Epidemiology and Infection.

[3]  T. Seemungal,et al.  Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. , 1999, The European respiratory journal.

[4]  G. Donaldson,et al.  COPD exacerbations · 1: Epidemiology , 2006, Thorax.

[5]  T. Seemungal,et al.  Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[6]  C Bryden,et al.  Stratification of COPD patients by previous admission for targeting of preventative care. , 2009, Respiratory medicine.

[7]  M Cazzola,et al.  Outcomes for COPD pharmacological trials: From lung function to biomarkers. , 2008, Revista portuguesa de pneumologia.

[8]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[9]  Robert A Wise,et al.  Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee , 2007, Thorax.

[10]  Julie Wallace,et al.  Atmospheric remote sensing to detect effects of temperature inversions on sputum cell counts in airway diseases. , 2010, Environmental research.

[11]  U. Lalloo.  The cough reflex and the "healthy smoker". , 2003, Chest.

[12]  S. Dowell,et al.  Seasonal variation in host susceptibility and cycles of certain infectious diseases. , 2001, Emerging infectious diseases.

[13]  E. Weitzenblum,et al.  Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[14]  M. Martínez-García,et al.  Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease , 2005, Thorax.

[15]  N. Johnston.  The similarities and differences of epidemic cycles of chronic obstructive pulmonary disease and asthma exacerbations. , 2007, Proceedings of the American Thoracic Society.

[16]  A. Pont,et al.  Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study , 2004, Thorax.

[17]  S. Aaron,et al.  Sex differences in the clinical presentation and management of airflow obstruction , 2006, European Respiratory Journal.

[18]  P. Ho,et al.  Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong , 2004, Journal of medical virology.

[19]  J. Wedzicha,et al.  Susceptibility to exacerbation in chronic obstructive pulmonary disease. , 2010, The New England journal of medicine.

[20]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[21]  H. Danahay,et al.  MUCOCILIARY CLEARANCE IS ENHANCED IN RAT MODELS OF CIGARETTE SMOKE AND LIPOPOLYSACCHARIDE-INDUCED LUNG DISEASE , 2004, Experimental lung research.

[22]  J. Garcia-Aymerich,et al.  Risk factors of readmission to hospital for a COPD exacerbation: a prospective study , 2003, Thorax.

[23]  P. Calverley,et al.  Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. , 2010, American journal of respiratory and critical care medicine.

[24]  K. R. Chapman,et al.  Epidemiology and costs of chronic obstructive pulmonary disease , 2006, European Respiratory Journal.

[25]  P. O'Byrne,et al.  Is nedocromil sodium effective treatment for asthma? , 1993, The European respiratory journal.

[26]  M. Niederman,et al.  Acute exacerbation of COPD: factors associated with poor treatment outcome. , 2000, Chest.

[27]  S. Hajat,et al.  Heat-related and cold-related deaths in England and Wales: who is at risk? , 2006, Occupational and Environmental Medicine.

[28]  Cécile Viboud,et al.  Influenza in Tropical Regions , 2006, PLoS medicine.

[29]  J. Hiller,et al.  Weather: driving force behind the transmission of severe acute respiratory syndrome in China? , 2007, Internal medicine journal.

[30]  Bartolome Celli,et al.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.

[31]  J Goodwin,et al.  Seasonal cold, excursional behaviour, clothing protection and physical activity in young and old subjects. , 2000, International journal of circumpolar health.

[32]  Paul Wilkinson,et al.  Vulnerability to winter mortality in elderly people in Britain: population based study , 2004, BMJ : British Medical Journal.

[33]  F. de la Igĺesia Martínez,et al.  [Chronic obstructive pulmonary disease and the seasons of the year]. , 2000, Archivos de bronconeumologia.

[34]  L. Shek,et al.  Epidemiology and seasonality of respiratory tract virus infections in the tropics. , 2003, Paediatric respiratory reviews.

[35]  P. Schnohr,et al.  Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study , 2006, Thorax.

[36]  G. Donaldson.  Cold exposure and winter mortality from ischaemic heart disease, cerebrovascular disease, respiratory disease, and all causes in warm and cold regions of Europe , 1997, The Lancet.

[37]  Tze Wai Wong,et al.  Temporal relationship between air pollutants and hospital admissions for chronic obstructive pulmonary disease in Hong Kong , 2007, Thorax.

[38]  R. Eccles,et al.  An Explanation for the Seasonality of Acute Upper Respiratory Tract Viral Infections , 2002, Acta oto-laryngologica.

[39]  D. Postma,et al.  Predictors of COPD symptoms: does the sex of the patient matter? , 2006, European Respiratory Journal.

[40]  S. Dowell,et al.  Seasonality of infectious diseases and severe acute respiratory syndrome–what we don't know can hurt us , 2004, The Lancet Infectious Diseases.

[41]  C. D. Mathers,et al.  Chronic obstructive pulmonary disease: current burden and future projections , 2006, European Respiratory Journal.

[42]  T. Seemungal,et al.  Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.